AGO2 |
Q9UKV8
|
argonaute RISC catalytic component 2
|
|
1.00 |
0.501 |
0.885 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ANXA1 |
P04083
|
annexin A1
|
|
1.2E-07 |
0.442 |
0.885 |
AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
BIRC5 |
O15392
|
baculoviral IAP repeat containing 5
|
Enzyme modulator
|
5.6E-02 |
0.495 |
0.731 |
CADM1 |
Q9BY67
|
cell adhesion molecule 1
|
|
0.66 |
0.491 |
0.769 |
CASP8 |
Q14790
|
caspase 8
|
Enzyme
|
3.7E-06 |
0.404 |
0.923 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CEACAM19 |
Q7Z692
|
CEA cell adhesion molecule 19
|
|
6.6E-10 |
0.780 |
0.308 |
CSN1S1 |
P47710
|
casein alpha s1
|
Storage
|
1.4E-16 |
0.780 |
0.346 |
DNMT3B |
Q9UBC3
|
DNA methyltransferase 3 beta
|
|
0.20 |
0.453 |
0.846 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
FAT1 |
Q14517
|
FAT atypical cadherin 1
|
|
1.2E-12 |
0.508 |
0.808 |
GPS1 |
Q13098
|
G protein pathway suppressor 1
|
|
1.00 |
0.769 |
0.346 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
KLK3 |
P07288
|
kallikrein related peptidase 3
|
Enzyme
|
4.4E-06 |
0.443 |
0.885 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
MGMT |
P16455
|
O-6-methylguanine-DNA methyltransferase
|
|
1.2E-07 |
0.412 |
0.885 |
MIR204 |
|
microRNA 204
|
|
|
0.487 |
0.808 |
PIK3CA |
P42336
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
Kinase
|
1.00 |
0.292 |
0.923 |
PIK3CB |
P42338
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
|
Kinase
|
1.00 |
0.322 |
0.885 |
PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |